Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.
M Hunault-BergerN MaillardC HimberlinC RecherA Schmidt-TanguyB ChoufiC BonmatiM CarréM-A CouturierE DaguindauJ-P MarolleauF Orsini-PiocelleJ DelaunayE TavernierS LissandreM Ojeda-UribeL SanhesL SuttonA BanosL M ForneckerM BernardD BouscaryA SaadMathieu PuyadeV RouilléI LuquetM C BénéJ-F HamelF DreyfusN IfrahA PigneuxPublished in: Blood cancer journal (2017)
Keyphrases
- phase ii
- poor prognosis
- acute myeloid leukemia
- clinical trial
- open label
- long non coding rna
- double blind
- phase iii
- allogeneic hematopoietic stem cell transplantation
- study protocol
- placebo controlled
- multiple myeloma
- middle aged
- newly diagnosed
- stem cell transplantation
- community dwelling
- cross sectional
- randomized controlled trial
- chronic lymphocytic leukemia
- low dose
- acute lymphoblastic leukemia